Ventilator-associated pneumonia due to Pseudomonas aeruginosa

Chest

Volumn 109, Issue 4, 1996, Pages 1019-1029

  Brewer, Susan Crouch ^a   Wunderink, Richard G ^a,b,c   Jones, Carol B ^a   Leeper Jr , Kenneth V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

antibiotic therapy; Pseudomonas; ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CILASTATIN; CIPROFLOXACIN; IMIPENEM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; INFECTIOUS COMPLICATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; STATISTICAL ANALYSIS; VENTILATOR;

EID: 0029863296     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.1019     Document Type: Article

References (39)

1. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-84
2. Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia: analysis of 172 episodes from a single metropolitan area Am Rev Respir Dis 1984; 128:668-71
3. Stevens RM, Teres D, Skilhnan JJ, et al. Pneumonia in an intensive care unit: a 30-month experience. Arch Intern Med 1974; 134:106-11
4. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-99
5. Buret A, Cripps AW. The immunoevasive activities of Pseudomonas aeruginosa: relevance for cystic fibrosis. Am Rev Respir Dis 1993; 148:793-805
6. Pollack M. The virulence of Pseudomonas aeruginosa. Rev Infect Dis 1984; 6:S617-26
7. Dever LA, Dermody TS. Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 1991; 151:886-95
8. Davis BD. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 1987; 51:341-50
9. Cullmann W, Buscher KH, Dick W. Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics. Eur J Clin Microbiol 1987; 6:467-73
10. Cook DJ, Fitzgerald JM, Guyatt GH, et al. Evaluation of the protected brush catheter and bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. J Intensive Care Med 1991; 6:196-205
11. Pingleton SK, Fagon JY, Leeper KV. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992; 102:553-58
12. Meduri GU, Wunderink RG, Leeper KV, et al. Management of bacterial pneumonia in ventilated patients: the role of protected bronchoalveolar lavage. Chest 1992; 101:500-08
13. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-36
14. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29
15. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-29
16. Wunderink RG, Mayhall CG, Gibert C. Methodology for clinical investigation of ventilator-associated pneumonia: epidemiology and therapeutic intervention. Chest 1992; 102:580-8S
17. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem/cilastatin. Antimicrob Agents Chemother 1994; 38:547-57
18. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-35
19. Wunderink RG. Mortality and ventilator-associated pneumonia: the best antibiotics may be the least antibiotics. Chest 1993; 104:993-95
20. Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. Crit Care Med 1995; 23:994-1006
21. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts poor outcome in ARDS. Chest 1995; 107:1062-73
22. Harris SE, Nelson S, Astry CL, et al. Endotoxin-induced suppression of pulmonary antibacterial defenses against Staphylococcus aureus. Am Rev Respir Dis 1988; 138:1439-43
23. Nelson S, Mason C, Kolls J, et al. Pathophysiology of pneumonia. Clin Chest Med 1995; 16:1-12
24. White JC, Nelson S, Winklestein JA, et al. Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J Infect Dis 1986; 153:202-08
25. Simpson SQ, Modi HN, Balk RA, et al. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 1991; 19:1060-66
26. Lugar A, Graf H, Schwarz HP, et al. Decreased serum interleukin-1 activity and monocyte interleukin-1 production in patients with fatal sepsis. Grit Gare Med 1986; 14:458-61
27. Richardson JD, De Camp MM, Garrison RN, et al. Pulmonary infections complicating intraabdominal sepsis. Ann Surg 1982; 195:732-37
28. Mandell LA, Marrie TJ, Niederman MS, et al. Initial antimicrobial treatment of hospital acquired pneumonia in adults: a conference report. Can J Infect Dis 1993; 4:317-21
29. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87:540-46
30. Wiener-Kronish JP, Sakuma T, Kudoh I, et al. Alveolar epithelial injury and pleural empyema in acute Pseudomonas aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol 1993; 75: 1661-69
31. Bergogne-Berezin E. Pharmacokinetics of antibiotics in respiratory secretions. In: Pennington JE, ed. Respiratory infections: diagnosis and management. New York: Raven Press, 1988; 608
32. Silver DR, Cohen IL, Weinberg PF. Recurrent Pseudomonas aeruginosa pneumonia in an intensive care unit. Chest 1992; 101:194-98
33. Niederman MS, Mantovani R, Schock P, et al. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989; 95:155-61
34. Winer-Muram HT, Jennings SG, Wunderink RG, et al. Ventilator-associated Pseudomosas aeruginosa pneumonia: radiographic findings. Radiology 1995; 195:247-52
35. Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infection in ventilated patients. Am Rev Respir Dis 1984; 130:924-29
36. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993; 147:38-44
37. A'Court CH, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Thorax 1992; 47:465-73
38. Nelson S, Bagby G, Summer W. Anti-tumor necrosis factor-alpha antibody suppresses pulmonary antibacterial defenses [abstract]. Am Rev Respir Dis 1991; 143S:393
39. Abraham E, Stevens P. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med 1992; 20:1127-33